您的购物车当前为空
别名 NSC644591 NSCD644591 SKI2053R, HTP, Heptaplatin Sunpla
Heptaplatin, a new platinum derivative with anticancer activity, is used against various cancer cell lines, including cisplatin-resistant cancer cell lines. It has been reported to have a response rate of 17% as a single agent, and tolerable toxicity in the treatment of advanced gastric cancer.

Heptaplatin, a new platinum derivative with anticancer activity, is used against various cancer cell lines, including cisplatin-resistant cancer cell lines. It has been reported to have a response rate of 17% as a single agent, and tolerable toxicity in the treatment of advanced gastric cancer.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 100 mg | ¥ 18,291 | 5日内发货 |
Heptaplatin 相关产品
| 产品描述 | Heptaplatin, a new platinum derivative with anticancer activity, is used against various cancer cell lines, including cisplatin-resistant cancer cell lines. It has been reported to have a response rate of 17% as a single agent, and tolerable toxicity in the treatment of advanced gastric cancer. |
| 别名 | NSC644591 NSCD644591 SKI2053R, HTP, Heptaplatin Sunpla |
| 分子量 | 471.36 |
| 分子式 | C11H20N2O6Pt |
| CAS No. | 146665-77-2 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | DMSO: Soluble H2O: Insoluble |
评论内容